SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-16-009100
Filing Date
2016-04-21
Accepted
2016-04-21 12:55:05
Documents
11
Period of Report
2016-04-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 23780
2 ex10-1.htm EX-10.1 5754
3 ex99-1.htm EX-99.1 10262
4 image_001.jpg GRAPHIC 333201
5 image_002.jpg GRAPHIC 373128
6 image_003.jpg GRAPHIC 457902
7 image_004.jpg GRAPHIC 336930
8 image_005.jpg GRAPHIC 199414
9 image_006.jpg GRAPHIC 357697
10 image_007.jpg GRAPHIC 397502
11 image_008.jpg GRAPHIC 81493
  Complete submission text file 0001493152-16-009100.txt   3536497
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 161583491
SIC: 2834 Pharmaceutical Preparations